Literature DB >> 27031943

Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016.

Emily E Petersen, Kara N D Polen, Dana Meaney-Delman, Sascha R Ellington, Titilope Oduyebo, Amanda Cohn, Alexandra M Oster, Kate Russell, Jennifer F Kawwass, Mateusz P Karwowski, Ann M Powers, Jeanne Bertolli, John T Brooks, Dmitry Kissin, Julie Villanueva, Jorge Muñoz-Jordan, Matthew Kuehnert, Christine K Olson, Margaret A Honein, Maria Rivera, Denise J Jamieson, Sonja A Rasmussen.   

Abstract

CDC has updated its interim guidance for U.S. health care providers caring for women of reproductive age with possible Zika virus exposure to include recommendations on counseling women and men with possible Zika virus exposure who are interested in conceiving. This guidance is based on limited available data on persistence of Zika virus RNA in blood and semen. Women who have Zika virus disease should wait at least 8 weeks after symptom onset to attempt conception, and men with Zika virus disease should wait at least 6 months after symptom onset to attempt conception. Women and men with possible exposure to Zika virus but without clinical illness consistent with Zika virus disease should wait at least 8 weeks after exposure to attempt conception. Possible exposure to Zika virus is defined as travel to or residence in an area of active Zika virus transmission ( http://www.cdc.gov/zika/geo/active-countries.html), or sex (vaginal intercourse, anal intercourse, or fellatio) without a condom with a man who traveled to or resided in an area of active transmission. Women and men who reside in areas of active Zika virus transmission should talk with their health care provider about attempting conception. This guidance also provides updated recommendations on testing of pregnant women with possible Zika virus exposure. These recommendations will be updated when additional data become available.

Entities:  

Mesh:

Year:  2016        PMID: 27031943     DOI: 10.15585/mmwr.mm6512e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  34 in total

1.  Persistence of Zika Virus in Body Fluids - Final Report.

Authors:  Gabriela Paz-Bailey; Eli S Rosenberg; Kate Doyle; Jorge Munoz-Jordan; Gilberto A Santiago; Liore Klein; Janice Perez-Padilla; Freddy A Medina; Stephen H Waterman; Carlos Garcia Gubern; Luisa I Alvarado; Tyler M Sharp
Journal:  N Engl J Med       Date:  2017-02-14       Impact factor: 91.245

2.  Sources affecting knowledge and behavior responses to the Zika virus in US households with current pregnancy, intended pregnancy and a high probability of unintended pregnancy.

Authors:  Man-Pui Sally Chan; Mohsen Farhadloo; Kenneth Winneg; Kathleen Hall Jamieson; Dolores Albarracin
Journal:  J Public Health (Oxf)       Date:  2018-12-01       Impact factor: 2.341

Review 3.  Zika clinical updates: implications for pediatrics.

Authors:  Kristina Adachi; Karin Nielsen-Saines
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

Review 4.  Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

Authors:  Matthew T Aliota; Leda Bassit; Shelton S Bradrick; Bryan Cox; Mariano A Garcia-Blanco; Christina Gavegnano; Thomas C Friedrich; Thaddeus G Golos; Diane E Griffin; Andrew D Haddow; Esper G Kallas; Uriel Kitron; Marc Lecuit; Diogo M Magnani; Caroline Marrs; Natalia Mercer; Edward McSweegan; Lisa F P Ng; David H O'Connor; Jorge E Osorio; Guilherme S Ribeiro; Michael Ricciardi; Shannan L Rossi; George Saade; Raymond F Schinazi; Geraldine O Schott-Lerner; Chao Shan; Pei-Yong Shi; David I Watkins; Nikos Vasilakis; Scott C Weaver
Journal:  Antiviral Res       Date:  2017-06-06       Impact factor: 5.970

Review 5.  Zika Virus Infection: Current Concerns and Perspectives.

Authors:  Mari Kannan Maharajan; Aruna Ranjan; Jian Feng Chu; Wei Lim Foo; Zhi Xin Chai; Eileen YinYien Lau; Heuy Mien Ye; Xi Jin Theam; Yen Ling Lok
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

6.  Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization.

Authors:  Marc-Antoine de La Vega; Jocelyne Piret; Bryan D Griffin; Chantal Rhéaume; Marie-Christine Venable; Julie Carbonneau; Christian Couture; Raquel das Neves Almeida; Roland R Tremblay; Kelly G Magalhães; Young K Park; Christine C Roberts; Joel N Maslow; Niranjan Y Sardesai; J Joseph Kim; Kar Muthumani; David B Weiner; Gary P Kobinger; Guy Boivin
Journal:  J Infect Dis       Date:  2019-01-09       Impact factor: 5.226

7.  In the midst of Zika pregnancy advisories, termination of pregnancy is the elephant in the room.

Authors:  Ara Aiken; C E Aiken; J Trussell
Journal:  BJOG       Date:  2016-09-05       Impact factor: 6.531

Review 8.  Zika virus infection and pregnancy: what we do and do not know.

Authors:  Carlo Ticconi; Adalgisa Pietropolli; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2016-09-30       Impact factor: 2.894

Review 9.  Zika virus - reigniting the TORCH.

Authors:  Carolyn B Coyne; Helen M Lazear
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

Review 10.  Epidemiology, Prevention, and Potential Future Treatments of Sexually Transmitted Zika Virus Infection.

Authors:  Davidson H Hamer; Mary E Wilson; Jenny Jean; Lin H Chen
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.